We’re taking a break for a few days at Science & Enterprise, and will resume our regular editorial posting this weekend. . . . → Read More: Taking a Break
|
|||||
We’re taking a break for a few days at Science & Enterprise, and will resume our regular editorial posting this weekend. . . . → Read More: Taking a Break A recent survey shows a solid bipartisan majority of U.S. adults favors at least some government regulation of artificial intelligence, including people who say they use A.I. . . . → Read More: Infographic – U.S. Public Backs A.I. Regulation A company creating a network of long-range high-altitude balloons to expand the scope of global weather forecasting is raising $6 million in seed funds. . . . → Read More: Weather Balloon Data Company Raises $6M in Seed Funds Results of a small clinical trial show genetically altered T-cells from patients with myasthenia gravis are well tolerated and reduce symptoms of the disease. . . . → Read More: Engineered T-Cells Shown Safe, Reduce Myasthenia Gravis A bioengineering lab created a system to make it easier for life scientists to use machine learning for data analysis, without writing their own algorithms. . . . → Read More: Automated Life Science A.I. Generation System Unveiled A new U.S. patent, licensed to a start-up biotechnology company, describes processes for linking together chains of synthetic peptides into therapeutic proteins. . . . → Read More: Patent Issued for Synthetic Peptide Chain Techniques A new biotechnology company is advancing research to find a comprehensive treatment for cystic fibrosis, and staked to a €2 million seed investment from its founder. . . . → Read More: Biotech Start-Up to Discover Cystic Fibrosis Therapy Employment in the technology industry is becoming more stable as layoffs by tech companies overall have steadily declined since the start of 2023. . . . → Read More: Infographic – Tech Layoffs Decline This Year A review of insurance claims shows patients facing obstacles to coverage for their migraine therapies are also more likely to need emergency care for treatment. . . . → Read More: Insurance Barriers, Migraine Hospital Visits Linked A synthetic biology company says it can now produce engineered cells from stem cells for research to precise specifications, and in large quantities and consistent quality. . . . → Read More: Synthetic Bio Company Manufactures Research Cells |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |